3 ms·
> updating their decision on safety as more data came in. That’s literally what they do. They paused when there were concerns over blood clots, then expanded a
by joshribakoff 5y ago
> updating their decision on safety as more data came in.
That’s literally what they do. They paused when there were concerns over blood clots, then expanded access to more cohorts as more studies were completed.
- acituan 5y ago"with minimal trial" is the operative word, which didn't happen. The point being there is a balance between waiting for perfect data and making risk based policies.